{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-135204","form_type":"8-K","ticker":"ITRMF","cik":"0001659323","company_name":"Iterum Therapeutics plc","filed_at":"2024-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.135044+00:00","generated_at":"2026-05-29T04:44:12.319997+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Iterum Therapeutics upsizes ATM offering by up to $25M, previously raised $16M","bullets":["Filed prospectus supplement on Dec 10, 2024 for additional gross proceeds up to $25M.","Prior sales under same ATM agreement totaled approx $16M gross proceeds.","Sales agent is H.C. Wainwright & Co., LLC under agreement dated Oct 7, 2022.","Shares offered via S-3 registration statement; legal opinion from A&L Goodbody LLP attached."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-135204","json":"https://secwatch.observer/filing/0000950170-24-135204.json","markdown":"https://secwatch.observer/filing/0000950170-24-135204.md","text":"https://secwatch.observer/filing/0000950170-24-135204.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659323/000095017024135204/0000950170-24-135204-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659323/000095017024135204/itrm-20241210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:44:12.319997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}